Post-COVID paediatric dysautonomia arises from complex interactions among central autonomic network dysfunction, neurovascular dysregulation, impaired venous return, endothelial injury, hypovolemia, and altered cerebral perfusion, with tachycardia often representing a compensatory physiological response rather than a primary cardiac abnormality.
This paper argues that post-COVID dysautonomia in children is primarily a brain-vascular network disorder, not a primary cardiac condition. Tachycardia is described as a compensatory response to underlying autonomic and vascular dysfunction. The authors emphasize the need for standardized assessment and exclusion of structural heart disease.
Evidence Score
Study Evidence
Study 1. Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?
observationalDas B, Moodley M · Cardiology in the young (2026)
Result:
Mechanism Graph
Limitations
- ⚠Reported prevalence varies widely due to evolving definitions and heterogeneous referral patterns
- ⚠Important gaps remain in disease definitions, mechanistic understanding, and evidence-based treatment
Frequently Asked Questions
Is post-COVID dysautonomia a heart problem?▼
No, the paper argues it is primarily a brain-vascular network disorder, with tachycardia being a compensatory response rather than a primary cardiac abnormality.
What are common symptoms of paediatric dysautonomia?▼
Common symptoms include dizziness, palpitations, exercise intolerance, fatigue, syncope, cognitive dysfunction, gastrointestinal symptoms, sleep disturbances, and post-exertional symptom exacerbation.
How should post-COVID dysautonomia be managed?▼
Management follows a stepwise approach including patient education, trigger avoidance, hydration and salt optimization, lower-body compression, individualized exercise rehabilitation, pacing strategies, school accommodations, and phenotype-directed pharmacotherapy.
What clinical phenotypes are associated with post-COVID dysautonomia?▼
Clinical phenotypes include postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, orthostatic hypotension, inappropriate sinus tachycardia, and undifferentiated orthostatic intolerance.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Das B, Moodley M. "Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?." Cardiology in the young, 2026. PMID: 42403377 DOI: 10.1017/S1047951126113900